Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Intas Pharma

- PMLiVE

Actavis sells EU generics businesses to Aurobindo

Divests operations in seven Western European countries

- PMLiVE

Salix Consulting launches UK pharmacy campaign

'Dispensing Health' aims to shift perceptions about community pharmacy

- PMLiVE

This month in 2000: The formation of GSK

The twenty-first century’s first ‘mega merger’

Biogen Idec building

Biogen Idec taps Sangamo for blood disorder drugs

Deal is worth up to $320m

- PMLiVE

Teva names Vigodman CEO and makes bid for NuPathe

Israeli pharma company confirms Jeremy Levin’s replacement

- PMLiVE

Key Teva shareholder backs Vigodman as next CEO

Board director tipped to replace Jeremy Levin at Israeli pharma firm

- PMLiVE

Pharma slammed by MPs for withholding trial data

Follows damning Tamiflu and data access report from UK's Public Accounts Committee

- PMLiVE

Skills in healthcare: pharmacy challenges in the UK

The challenges today’s pharmacists face

- PMLiVE

AZ faces early competition to Nexium in the US

Korea's Hanmi and Amneal Pharmaceuticals launches first generic rival

- PMLiVE

Endo builds pain management business

Agrees $105m deal to acquire NuPathe

- PMLiVE

Teva’s vice chair steps down

Amir Elstein to take over from Moshe Many

- PMLiVE

J&J extends partnering network in UK

Will open offices in life sciences ‘hotspots’

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links